CONMED Corporation
CNMD
$54.73
$0.450.83%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.77% | 44.20% | 105.44% | 127.25% | 11.68% |
| Total Depreciation and Amortization | 1.93% | 0.56% | 0.40% | 0.93% | 1.14% |
| Total Amortization of Deferred Charges | -5.83% | -6.83% | -8.48% | -8.67% | -6.75% |
| Total Other Non-Cash Items | 91.97% | -31.55% | -114.59% | -62.15% | 117.63% |
| Change in Net Operating Assets | -312.86% | -61.32% | -0.37% | 84.71% | 88.27% |
| Cash from Operations | -5.57% | 13.31% | 33.20% | 213.88% | 371.29% |
| Capital Expenditure | -6.89% | 11.81% | 31.25% | 29.99% | 25.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 185.00% | -- | 100.00% | 100.00% |
| Cash from Investing | -1.53% | 21.53% | 34.68% | 35.34% | 85.21% |
| Total Debt Issued | -19.45% | -14.23% | 8.53% | 19.24% | 32.31% |
| Total Debt Repaid | 17.06% | 10.35% | -5.51% | -24.93% | -59.47% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.41% | -0.49% | -0.61% | -0.72% | -0.86% |
| Other Financing Activities | 35.56% | -28.93% | -2,725.56% | -479.64% | -451.89% |
| Cash from Financing | 7.81% | -22.28% | -36.74% | -295.25% | -457.41% |
| Foreign Exchange rate Adjustments | 183.33% | -301.45% | -678.94% | -62.82% | -197.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 396.18% | -77.86% | 103.51% | 379.28% | 104.03% |